These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 34193814

  • 1. Urinary sediment microRNAs can be used as potential noninvasive biomarkers for diagnosis, reflecting the severity and prognosis of diabetic nephropathy.
    Han Q, Zhang Y, Jiao T, Li Q, Ding X, Zhang D, Cai G, Zhu H.
    Nutr Diabetes; 2021 Jun 30; 11(1):24. PubMed ID: 34193814
    [Abstract] [Full Text] [Related]

  • 2. Increased urinary miR-196a level predicts the progression of renal injury in patients with diabetic nephropathy.
    An Y, Zhang C, Xu F, Li W, Zeng C, Xie L, Liu Z.
    Nephrol Dial Transplant; 2020 Jun 01; 35(6):1009-1016. PubMed ID: 30521014
    [Abstract] [Full Text] [Related]

  • 3. Selection of urinary sediment miRNAs as specific biomarkers of IgA nephropathy.
    Duan ZY, Cai GY, Bu R, Lu Y, Hou K, Chen XM.
    Sci Rep; 2016 Mar 22; 6():23498. PubMed ID: 27000966
    [Abstract] [Full Text] [Related]

  • 4. Urinary sediment miRNAs reflect tubulointerstitial damage and therapeutic response in IgA nephropathy.
    Liang S, Cai GY, Duan ZY, Liu SW, Wu J, Lv Y, Hou K, Li ZX, Zhang XG, Chen XM.
    BMC Nephrol; 2017 Feb 15; 18(1):63. PubMed ID: 28201996
    [Abstract] [Full Text] [Related]

  • 5. Plasma miR-193a-3p can be a potential biomarker for the diagnosis of diabetic nephropathy.
    Hong Y, Wang J, Zhang L, Sun W, Xu X, Zhang K.
    Ann Clin Biochem; 2021 Mar 15; 58(2):141-148. PubMed ID: 33302703
    [Abstract] [Full Text] [Related]

  • 6. Micro-RNA expression in the urinary sediment of patients with chronic kidney diseases.
    Szeto CC, Ching-Ha KB, Ka-Bik L, Mac-Moune LF, Cheung-Lung CP, Gang W, Kai-Ming C, Kam-Tao LP.
    Dis Markers; 2012 Mar 15; 33(3):137-44. PubMed ID: 22960330
    [Abstract] [Full Text] [Related]

  • 7. [The clinicopathological characteristics of diabetic nephropathy and non-diabetic renal diseases in diabetic patients].
    Xu J, Hu XF, Huang W, Shen PY, Zhang W, Ren H, Li X, Wang WM, Chen N, Pan XX.
    Zhonghua Nei Ke Za Zhi; 2017 Dec 01; 56(12):924-929. PubMed ID: 29202533
    [Abstract] [Full Text] [Related]

  • 8. Clinicopathological study of nondiabetic renal disease in type 2 diabetic patients: A single center experience from India.
    Kanodia KV, Vanikar AV, Nigam L, Patel RD, Suthar KS, Patel H.
    Saudi J Kidney Dis Transpl; 2017 Dec 01; 28(6):1330-1337. PubMed ID: 29265044
    [Abstract] [Full Text] [Related]

  • 9. Decreased Urine miR-199-3p may be a Potential Biomarker for Diabetic Nephropathy via Targeting Zinc Finger E-box-Binding Protein 1.
    Meng L, Li G, Liu X, Jiang J, Zhu M, Sun Y.
    Clin Lab; 2018 Jul 01; 64(7):1177-1182. PubMed ID: 30146830
    [Abstract] [Full Text] [Related]

  • 10. Urinary Exosomal MicroRNAs as New Noninvasive Biomarkers of IgA Nephropathy.
    Li S, Hao H, Li R, Guo S.
    Tohoku J Exp Med; 2022 Mar 01; 256(3):215-223. PubMed ID: 35314529
    [Abstract] [Full Text] [Related]

  • 11. Renal pathological implications in type 2 diabetes mellitus patients with renal involvement.
    Li L, Zhang X, Li Z, Zhang R, Guo R, Yin Q, Yang L, Yue R, Su B, Huang S, Xu H, He C, Liu F.
    J Diabetes Complications; 2017 Jan 01; 31(1):114-121. PubMed ID: 27838100
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic Value of Urinary miR-152-5p in Patients with IgA Nephropathy with Elevated Proteinuria Levels.
    Duan A, Liu L, Lou Y, Zhang D, Li H, Chen Y, Cui W, Miao L.
    Clin Lab; 2019 Jul 01; 65(7):. PubMed ID: 31307184
    [Abstract] [Full Text] [Related]

  • 13. Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis.
    Eissa S, Matboli M, Bekhet MM.
    Biomed Pharmacother; 2016 Oct 01; 83():92-99. PubMed ID: 27470555
    [Abstract] [Full Text] [Related]

  • 14. Urinary miR-16-5p can be used as a potential marker of endocapillary hypercellularity in IgA nephropathy.
    Zhang M, Duan ZY, Zhang QY, Xu XG, Zhang Y, Wang P, Duan SW, Wu J, Chen XM, Cai GY.
    Sci Rep; 2023 Apr 13; 13(1):6048. PubMed ID: 37055445
    [Abstract] [Full Text] [Related]

  • 15. Prognostic value of risk score and urinary markers in idiopathic membranous nephropathy.
    van den Brand JA, Hofstra JM, Wetzels JF.
    Clin J Am Soc Nephrol; 2012 Aug 13; 7(8):1242-8. PubMed ID: 22595828
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Urinary miRNA profile for the diagnosis of IgA nephropathy.
    Szeto CC, Wang G, Ng JK, Kwan BC, Mac-Moune Lai F, Chow KM, Luk CC, Lai KB, Li PK.
    BMC Nephrol; 2019 Mar 04; 20(1):77. PubMed ID: 30832601
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.